Event Details
Tickets
Sponsorship
Tastemakers
Our Mission
Contact
Your Welcome Message Here
Join our Tastemakers in supporting this incredible cause. Learn more about their individual stories and how cancer has affected their lives.
Welcome message from your Committee Chair/Co-Chairs
The American Cancer Society Cancer Action Network (ACS CAN) advocates for evidence-based public policies to reduce the cancer burden for everyone. We engage our volunteers across the country to make their voices heard by policymakers at every level of government. We believe everyone should have a fair and just opportunity to prevent, detect, treat, and survive cancer.
Since 2001, as the American Cancer Society’s nonprofit, nonpartisan advocacy affiliate, ACS CAN has successfully advocated for billions of dollars in cancer research funding, expanded access to quality affordable health care, and advanced proven tobacco control measures.
We stand with our volunteers—people whose lives have been impacted by cancer—rallying to demand change. Together, we’re working to make cancer a top priority for public officials and candidates at the federal, state, and local levels. By engaging advocates across the country to make their voices heard, ACS CAN influences legislative and regulatory solutions that will end cancer as we know it, for everyone.
Learn MoreFor more than 2 decades, the American Cancer Society Cancer Action Network has been dedicated to pursing better outcomes for every cancer, every life. Today, more people are surviving cancer than ever before, but there is still work to be done. Join us, support us, and help us end cancer as we know it, for everyone.
Protected and secured $4.8 billion in state appropriations through advocacy to help fund cancer research and programs that reduce the tobacco burden and increase access to screenings.
Held the tobacco industry responsible for decades of public deceit through a requirement for companies to post truthful statements about their deadly products at nearly 220,000 retail outlets nationwide.
Expand insurance coverage of comprehensive biomarker testing in over 10 states and counting.
